British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

A complaint against GSK accusing it of a major breach of the pharma industry's code of practice on prescribing information ...

GSK has been found guilty of bringing discredit on the pharma industry after a complainan | GSK has been found guilty of ...

UK pharm major GSK (LSE: GSK) has breached the ABPI Code of Practice for the Industry and brought discredit upon, and ...

Earlier treatment options for managing myelofibrosis-related anaemia have demonstrated limited efficacy and durability of response; and while JAK inhibitors are often used, they can sometimes ...

(Reuters) -British pharmaceutical giant GSK has not met required ethical and regulatory standards in its marketing and ...

GSK's submission for the approval of Omjjara was supported by data from the pivotal MOMENTUM study and a subpopulation of adult patients with anaemia from the SIMPLIFY-1 phase III trial. MOMENTUM was ...

London: British pharmaceutical major GlaxoSmithKline (GSK) has failed to meet the required regulatory and ethical standards ...

and over 30% will discontinue treatment due to anaemia [1-3] Omjjara addresses the key manifestations of myelofibrosis, specifically anaemia, constitutional symptoms, and splenomegaly Earlier ...